Cholestyramine for Oral Suspension
- Product NDC
- 62135-008
- 11-digit product format
- 621350008
- Labeler code
- 62135
- Product ID
- 62135-008_f1d8692b-deb3-d55f-e053-2a95a90ae615
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cholestyramine for Oral Suspension
- Dosage form
- POWDER
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA074561
- Marketing category
- ANDA
- Marketing start
- 1996-08-15
- Substance
- CHOLESTYRAMINE
- Active strength
- 4 g/9g
- Pharmacologic classes
- Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cholestyramine for Oral Suspension
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHOLESTYRAMINE | 4 g/9g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4B33BGI082 |
| Rxcui | 848943, 1801279 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-008-56 | Cholestyramine for Oral Suspension | 378 g in 1 CAN | POWDER | 378 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-008 | CHOLESTYRAMINE FOR ORAL SUSPENSION POWDER [CHARTWELL RX, LLC] | 1 | Current NDC, Legacy NDC, 1 package rows | 20230110_80db0042-0c05-4509-8a6b-fa9f4783629a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62135-008-56 | 62135000856 | 378 g in 1 CAN (62135-008-56) | 378 g | 2023-01-03 | 0000-00-00 | No | No | Current |